HEALTH
February 13, 2012 | Jessica Pauline Ogilvie
Asthma sufferers have long relied on inhalers for relief from wheezing or coughing attacks. But as of Dec. 31, Primatene Mist -- the only available over-the-counter asthma inhaler -- was taken off shelves because of its adverse effect on the environment. Other inhalers are available, but these require a doctor's prescription. Some people with asthma aren't happy about the change, but lung doctors and asthma specialists agree that Primatene Mist wasn't the best option for patients anyway.
HEALTH
August 17, 2009 | Francesca Lunzer Kritz
Times are tough enough for Californians; they're even tougher for Californians' teeth. "One-quarter of all adults and 28% of children in California have untreated dental caries [cavities]," says Len Finocchio, a senior program officer at the California Healthcare Foundation, a health advocacy group. "Our research tells us that many people in California have been avoiding routine care that might have cost about $100 for a checkup and cleaning, and then find themselves in the emergency room, where they get only an antibiotic, a bill that can average over $600 and instructions to see a dentist."
NEWS
May 17, 2012 | By Eryn Brown, Los Angeles Times / for the Booster Shots blog
Disco legend Donna Summer, 63, died Wednesday night, reportedly of lung cancer. As of press time, her family hadn't released details about her illness, so it was unknown what type of lung cancer she had, and how long she may have been ailing. According to the American Cancer Society , lung cancer is the leading cause of cancer death in both women and men, killing more than 150,000 people per year -- more than colon, breast, ovarian and prostate cancers combined. In 2012, the group estimates, there will be about 226,000 new cases of lung cancer in the U.S. Survival rates of people with lung cancer are low. Only about half of people diagnosed with early-stage non-small-cell lung cancer (the more common type)
HEALTH
March 30, 2009 | Judy Foreman
Manny Hamelburg, 68, a retired businessman, had fought prostate cancer for years. First, he tried radiation, then a drug with side effects that nearly killed him, and finally Lupron, a drug that blocks production of testosterone, the hormone that can fuel prostate cancer. The cancer disappeared. But life was miserable. Without normal levels of testosterone, Hamelburg says, he had no energy, and "zero libido for seven years. I was like a eunuch. I was chemically castrated. Sex was just hugs."
SCIENCE
May 22, 2012 | By Rosie Mestel, Los Angeles Times
The PSA test should be abandoned as a prostate cancer screening tool, a government advisory panel has concluded after determining that the side effects from needless biopsies and treatments hurt many more men than are potentially helped by early detection of cancers. At best, one life will be saved for every 1,000 men screened over a 10-year period, according to the U.S. Preventive Services Task Force. But 100 to 120 men will have suspicious results when there is no cancer, triggering biopsies that can carry complications such as pain, fever, bleeding, infection and hospitalization.
NATIONAL
May 10, 2012 | By Ian Duncan, Los Angeles Times
WASHINGTON - An experimental treatment for multiple sclerosis has caused death, strokes, nerve damage and abdominal bleeding and has no proven benefits for sufferers of the disease, the Food and Drug Administration warned Thursday. Known as liberation therapy, the treatment targets chronic cerebrospinal venous insufficiency - or CCSVI - a narrowing of the veins in the head and neck. It involves inserting balloons or stents into veins to widen them in an attempt to relieve the symptoms of MS. The FDA received reports in 2011 of a patient who died from bleeding in the brain after undergoing the treatment and another who was left permanently paralyzed by a stroke.